13th Tetrahedron Symposium
26 - 29 June 2012, Amsterdam, The Netherlands
» Registration Now Open! – Click here
» Information on Conference Dinner is now available – Click here
Call for Abstracts
Closed for the Netherlands conference.
Open for the Taiwan conference: Click here to submit!
This website is dedicated to the Amsterdam conference in June 2012. Join us to hear from an outstanding line up of invited speakers and to present your work as a poster.
View Professor Neidle’s Invitation here.
If you would like to get a video an impression of a previous Elsevier conference held at the same venue, please click here.
Attendance at this meeting will enable to you to:
- Learn from internationally renowned researchers in a comprehensive programme covering all areas of chemical biology, synthetic, bioorganic and medicinal chemistry
- Understand the current state of research and the challenges to future discovery.
- Present your latest research in the poster sessions.
- Network with the editors of the Tetrahedron journals, meet with international colleagues, visit the trade stands and grow your LinkedIn connections
- Experience a UNESCO World Heritage City in your free time!
Symposium Topics so far include:
- Sequencing nucleic acids: from chemistry to life sciences and medicine
- Oligonucleotide-based tools for pharmacology and nano-engineering
- The future of kinase drug discovery
- challenges and opportunities - Vaccines as a new paradigm for the treatment of drug addiction
- Fragment-based drug discovery:
a decade of thinking small - Chemical biology of nanomedicines
- Modulation of DNA damage-response pathways in cancer therapy
- The chemical biology of protein splicing
- Molecular design for selective recognition and reaction with RNA Target identification for biologically relevant small molecules
- Total Synthesis as a Vehicle for Interrogating Biosynthetic and Biomechanistic Puzzles
Invited Speakers
Shankar Balasubramanian, University of Cambridge, UK
Clifton Barry, NIH, USA
Ben Davis, University of Oxford, UK
Michael Famulok, University of Bonn, Germany
Ben Feringa, University of Groningen, The Netherlands
Carlos Garcia-Echeverria, Sanofi-Aventis, France
Roger Griffin, University of Newcastle, UK
Kim Janda, Scripps Institute, USA
Harren Jhoti, Astex UK
Kostas Kostarelos, University College London, UK
Richard Lerner, Scripps Institute, USA
Tom Muir, Rockefeller University, USA
Shigeki Sasaki, Kyushu University, Japan
Zhang-Jie Shi, Peking University, China
Greg Verdine, Harvard University, USA
Herbert Waldmann, MPI, Dortmund, Germany
Robert M. Williams, Colorado State University, USA
Shankar Balasubramanian, University of Cambridge, UK
Clifton Barry, NIH, USA
Ben Davis, University of Oxford, UK
Michael Famulok, University of Bonn, Germany
Ben Feringa, University of Groningen, The Netherlands
Carlos Garcia-Echeverria, Sanofi-Aventis, France
Roger Griffin, University of Newcastle, UK
Kim Janda, Scripps Institute, USA
Harren Jhoti, Astex UK
Kostas Kostarelos, University College London, UK
Richard Lerner, Scripps Institute, USA
Tom Muir, Rockefeller University, USA
Shigeki Sasaki, Kyushu University, Japan
Zhang-Jie Shi, Peking University, China
Greg Verdine, Harvard University, USA
Herbert Waldmann, MPI, Dortmund, Germany
Robert M. Williams, Colorado State University, USA
Organised by
Supporting publication
